NCT00091260 - CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

July 31, 2012

Study Completion Date

May 31, 2015

Conditions

Multiple Myeloma

Interventions

DRUG

dexamethasone

dexamethasone 20 mg daily (10 mg BID) on Days 1-4, 9-12, and 17-20 of every other 28-day cycle.

DRUG

lenalidomide

15 mg/day, for 21 days with 7 days rest (28 day cycle) with or without dexamethasone

Trial Locations (1)

Cancer Research Center at Boston Medical Center, Boston